231 related articles for article (PubMed ID: 22760780)
41. Glucocorticoid hormone treatment enhances the cytokine production of regulatory T cells by upregulation of Foxp3 expression.
Ugor E; Prenek L; Pap R; Berta G; Ernszt D; Najbauer J; Németh P; Boldizsár F; Berki T
Immunobiology; 2018; 223(4-5):422-431. PubMed ID: 29223294
[TBL] [Abstract][Full Text] [Related]
42. CD25 signaling regulates the function and stability of peripheral Foxp3+ regulatory T cells derived from the spleen and lymph nodes of mice.
Wang K; Gu J; Ni X; Ding Z; Wang Q; Zhou H; Zheng S; Li B; Lu L
Mol Immunol; 2016 Aug; 76():35-40. PubMed ID: 27344615
[TBL] [Abstract][Full Text] [Related]
43. The different effects of indirubin on effector and CD4+CD25+ regulatory T cells in mice: potential implication for the treatment of autoimmune diseases.
Zhang A; Qu Y; Zhang B; Zhang L; Zeng C; Peng J; Ji X; Hou M; Zhao Y
J Mol Med (Berl); 2007 Nov; 85(11):1263-70. PubMed ID: 17639287
[TBL] [Abstract][Full Text] [Related]
44. Enhancing regulatory T-cell function via inhibition of high mobility group box 1 protein signaling in immune thrombocytopenia.
Wang H; Yu T; An N; Sun Y; Xu P; Han P; Zhao Y; Wang L; Ni X; Li Y; Li G; Liu Y; Peng J; Hou M; Hou Y
Haematologica; 2023 Mar; 108(3):843-858. PubMed ID: 36263841
[TBL] [Abstract][Full Text] [Related]
45. Increased natural CD4+CD25+ regulatory T cells and their suppressor activity do not contribute to mortality in murine polymicrobial sepsis.
Scumpia PO; Delano MJ; Kelly KM; O'Malley KA; Efron PA; McAuliffe PF; Brusko T; Ungaro R; Barker T; Wynn JL; Atkinson MA; Reeves WH; Salzler MJ; Moldawer LL
J Immunol; 2006 Dec; 177(11):7943-9. PubMed ID: 17114466
[TBL] [Abstract][Full Text] [Related]
46. B7-1 and B7-2 differentially control peripheral homeostasis of CD4(+)CD25(+)Foxp3(+) regulatory T cells.
Zeng M; Guinet E; Nouri-Shirazi M
Transpl Immunol; 2009 Jan; 20(3):171-9. PubMed ID: 18848987
[TBL] [Abstract][Full Text] [Related]
47. Changes of CD4+CD25+Foxp3+ regulatory T cells in aged Balb/c mice.
Zhao L; Sun L; Wang H; Ma H; Liu G; Zhao Y
J Leukoc Biol; 2007 Jun; 81(6):1386-94. PubMed ID: 17369496
[TBL] [Abstract][Full Text] [Related]
48. CD4(+) CD25(+) regulatory T cells ameliorate Behcet's disease-like symptoms in a mouse model.
Shim J; Lee ES; Park S; Bang D; Sohn S
Cytotherapy; 2011 Aug; 13(7):835-47. PubMed ID: 21506890
[TBL] [Abstract][Full Text] [Related]
49. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
[TBL] [Abstract][Full Text] [Related]
50. In vitro TNF blockade enhances ex vivo expansion of regulatory T cells in patients with immune thrombocytopenia.
Zhong H; Bussel J; Yazdanbakhsh K
Br J Haematol; 2015 Jan; 168(2):274-83. PubMed ID: 25252160
[TBL] [Abstract][Full Text] [Related]
51. Decrease of CD4(+) CD25(+) CD127(low) FoxP3(+) regulatory T cells with impaired suppressive function in untreated ulcerative colitis patients.
Mohammadnia-Afrouzi M; Zavaran Hosseini A; Khalili A; Abediankenari S; Hosseini V; Maleki I
Autoimmunity; 2015; 48(8):556-61. PubMed ID: 26333292
[TBL] [Abstract][Full Text] [Related]
52. Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents.
Bao W; Bussel JB; Heck S; He W; Karpoff M; Boulad N; Yazdanbakhsh K
Blood; 2010 Nov; 116(22):4639-45. PubMed ID: 20688957
[TBL] [Abstract][Full Text] [Related]
53. Tolerogenic dendritic cells induce CD4+CD25hiFoxp3+ regulatory T cell differentiation from CD4+CD25-/loFoxp3- effector T cells.
Huang H; Dawicki W; Zhang X; Town J; Gordon JR
J Immunol; 2010 Nov; 185(9):5003-10. PubMed ID: 20870943
[TBL] [Abstract][Full Text] [Related]
54. Drug-induced thrombocytopenia: development of a novel NOD/SCID mouse model to evaluate clearance of circulating platelets by drug-dependent antibodies and the efficacy of IVIG.
Liang SX; Pinkevych M; Khachigian LM; Parish CR; Davenport MP; Chong BH
Blood; 2010 Sep; 116(11):1958-60. PubMed ID: 20566900
[TBL] [Abstract][Full Text] [Related]
55. The abnormal function of CD39
Lu Y; Cheng L; Li F; Ji L; Shao X; Wu B; Zhan Y; Liu C; Min Z; Ke Y; Sun L; Chen H; Cheng Y
Ann Hematol; 2019 Aug; 98(8):1845-1854. PubMed ID: 31154474
[TBL] [Abstract][Full Text] [Related]
56. Depletion of natural CD4+CD25+ T regulatory cells with anti-CD25 antibody does not change the course of Pseudomonas aeruginosa-induced acute lung infection in mice.
Carrigan SO; Yang YJ; Issekutz T; Forward N; Hoskin D; Johnston B; Lin TJ
Immunobiology; 2009; 214(3):211-22. PubMed ID: 19215803
[TBL] [Abstract][Full Text] [Related]
57. The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice.
Qu Y; Zhang B; Zhao L; Liu G; Ma H; Rao E; Zeng C; Zhao Y
Transpl Immunol; 2007 Apr; 17(3):153-61. PubMed ID: 17331841
[TBL] [Abstract][Full Text] [Related]
58. Toll-like receptor 2-mediated modulation of growth and functions of regulatory T cells by oral streptococci.
Saeki A; Segawa T; Abe T; Sugiyama M; Arimoto T; Hara H; Hasebe A; Ohtani M; Tanizume N; Ohuchi M; Kataoka H; Kawanami M; Yokoyama A; Shibata K
Mol Oral Microbiol; 2013 Aug; 28(4):267-80. PubMed ID: 23413817
[TBL] [Abstract][Full Text] [Related]
59. Thrombopoietin receptor agonist (TPO-RA) treatment raises platelet counts and reduces anti-platelet antibody levels in mice with immune thrombocytopenia (ITP).
Kapur R; Aslam R; Speck ER; Rebetz JM; Semple JW
Platelets; 2020; 31(3):399-402. PubMed ID: 31146647
[TBL] [Abstract][Full Text] [Related]
60. High Thymic Output of Effector CD4
Zhao Y; Alard P; Kosiewicz MM
J Immunol Res; 2019; 2019():8785263. PubMed ID: 31281853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
